RESEARCH-USE BIOSIMILAR ANTIBODY
Cudarolimab
Monoclonal antibody · IgG1
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research.
TARGETTNFRSF4
YMonoclonal antibody
CATALOGSC-BS-646
CATALOG NUMBERSC-BS-646
MOLECULAR WEIGHTApprox. 145.94 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research.
Cudarolimab is a recombinant research-use antibody directed against TNFRSF4.